373
Participants
Start Date
July 31, 2008
Primary Completion Date
April 30, 2009
Study Completion Date
April 30, 2009
AZD5672
20 mg oral, once daily
Etanercept
50 mg, subcutaneous injection, weekly
Placebo
placebo, oral, once daily
AZD5672
50 mg oral, once daily
AZD5672
100 mg oral, once daily
AZD5672
150 mg oral, once daily
Research Site, Blagoevgrad
Research Site, Plovdiv
Research Site, Sofia
Research Site, Medellín
Research Site, Bogotá
Research Site, Bucaramanga
Research Site, Česká Lípa
Research Site, České Budějovice
Research Site, Hlučín
Research Site, Pardubice
Research Site, Prague
Research Site, Praha 11 - Chodov
Research Site, Zlín
Research Site, Békéscsaba
Research Site, Budapest
Research Site, Debrecen
Research Site, Kecskemét
Research Site, Makó
Research Site, Sopron
Research Site, Siena
Research Site, Valmiera
Research Site, Birkirkara
Research Site, Bialystok
Research Site, Działdowo
Research Site, Krakow
Research Site, Lublin
Research Site, Sopot
Research Site, Szczecin
Research Site, Torun
Research Site, Warsaw
Research Site, Wroclaw
Research Site, Brasov
Research Site, Bucharest
Research Site, Ploieşti
Research Site, Saint Petersburg
Research Site, Yaroslavl
Research Site, Belgrade
Research Site, Niška Banja
Research Site, Banská Bystrica
Research Site, Bratislava
Research Site, Piešťany
Research Site, Pretoria
Research Site, Durban
Research Site, Cape Town
Research Site, Donetsk
Research Site, Ivano-Frankivsk
Research Site, Kiev
Research Site, Kyiv
Research Site, Simferopol
Lead Sponsor
AstraZeneca
INDUSTRY